Yu J D, Zhao H, Fang Y H, Luo Y Y, Lou J G, Chen J
Department of Gastroenterology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310057, China.
Zhonghua Gan Zang Bing Za Zhi. 2025 Feb 20;33(2):170-176. doi: 10.3760/cma.j.cn501113-20240611-00291.
To analyze the clinical and genetic features of four children with pediatric acute liver failure (PALF) caused by neuroblastoma-amplified sequence () gene variant, as well as the correlation between clinical phenotype and genotype. The clinical data and genetic test results of four children with gene variants admitted to the Department of Gastroenterology, Children's Hospital Affiliated to Zhejiang University School of Medicine from August 2015 to June 2023 mainly presenting with pediatric acute liver failure (PALF) were retrospectively analyzed. The relevant literature from January 2015 to May 2024 was retrieved using the Chinese and English keywords "," "neuroblastoma amplified sequence," "SOPH," "short stature with optic nerve atrophy and Pelger Huët anomaly," "liver failure," and "neuroblastoma amplified sequence" indexed in the CNKI database, Wanfang Data Knowledge Service Platform, and PubMed database. The clinical features and gene mutation characteristics of domestic patients were summarized. The age at which the initial PALF attack occurred in the four children varied from eight months to three years and seven months. All patients developed PALF within 1-2 days after the onset of fever, with symptoms such as vomiting, convulsions, and mental depression or confusion, accompanied by a sharp increase in transaminases, elevated bilirubin and blood ammonia, hyperlactatemia, and hepatomegaly. The PALF gradually improved, and three pediatric patients showed extrahepatic manifestations following antipyretic, fluid replacement, and other symptomatic supportive treatment. Long-term follow-up showed that active temperature control and symptomatic therapy reduced the recurrence of PALF. Genetic testing identified eight kinds of gene variants sites. Family testing validated compound heterozygous variants, which included four missense variants, one nonsense variants, and three frameshift mutations. A literature study revealed that out of 51 Chinese patients with gene variants, 98.0% (50/51) had liver involvement, and 37 cases showed PALF. A total of 61 mutation sites were identified, with c.3596G>A (45.1%, 23/51) as a hotspot variants. PALF caused by gene variant has obvious clinical and genetic characteristics, and there is a correlation between genotype and clinical phenotype. The c.3596G>A variant site is a hotspot mutation in China and is strongly correlated with the liver failure phenotype.
分析4例由神经母细胞瘤扩增序列()基因变异引起的儿童急性肝衰竭(PALF)的临床及遗传学特征,以及临床表型与基因型之间的相关性。回顾性分析2015年8月至2023年6月浙江大学医学院附属儿童医院消化内科收治的4例以儿童急性肝衰竭(PALF)为主要表现的基因变异患儿的临床资料及基因检测结果。通过在中国知网数据库、万方数据知识服务平台以及PubMed数据库中检索2015年1月至2024年5月期间的相关文献,检索词为中文关键词“”“神经母细胞瘤扩增序列”“SOPH”“矮小伴视神经萎缩和Pelger Huët异常”“肝衰竭”以及英文关键词“neuroblastoma amplified sequence”“SOPH”“short stature with optic nerve atrophy and Pelger Huët anomaly”“liver failure”“neuroblastoma amplified sequence”,总结国内患者的临床特征及基因突变特点。4例患儿首次发生PALF的年龄为8个月至3岁7个月。所有患者均在发热起病后1 - 2天内出现PALF,伴有呕吐、惊厥、精神萎靡或意识模糊等症状,同时伴有转氨酶急剧升高、胆红素及血氨升高、高乳酸血症和肝脏肿大。PALF逐渐好转,3例患儿经退热、补液等对症支持治疗后出现肝外表现。长期随访显示,积极控制体温及对症治疗可降低PALF的复发率。基因检测共发现8种基因变异位点。家系检测验证为复合杂合变异,其中包括4种错义变异、1种无义变异和3种移码突变。文献研究显示,51例基因变异的中国患者中,98.0%(50/51)有肝脏受累,37例表现为PALF。共鉴定出61个突变位点,其中c.3596G>A(45.1%,23/51)为热点变异。由基因变异引起的PALF具有明显的临床及遗传学特征,基因型与临床表型之间存在相关性。c.3596G>A变异位点是中国的热点突变,与肝衰竭表型密切相关。